PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32801691-7	2020	In combination therapy with Doxil, only the administration of anti-CTLA-4 before Doxil showed synergism in both non-liposomal and liposomal form and increased the CD8+/regulatory T cell ratio.	liposomal doxorubicin	28-33	cytotoxic T-lymphocyte-associated protein 4	Mus musculus	67-73	
32042344-9	2020	Furthermore, we found that combining tranilast with Doxil nanomedicine, significantly improved immunostimulatory M1 macrophage content in the tumorigenic tissue and improved the efficacy of the immune checkpoint blocking antibodies anti-PD-1/anti-CTLA-4.	liposomal doxorubicin	52-57	cytotoxic T-lymphocyte-associated protein 4	Mus musculus	247-253